PharOS Mt Ltd
PolandAll medications by this manufacturer
-
Formetic sr
Form: tablets, prolonged release
Active substance Dosage Metformin hydrochloride 500 mg ATC: A10BA02
-
Formetic sr
Form: tablets, prolonged release
Active substance Dosage Metformin hydrochloride 750 mg ATC: A10BA02
-
Igzelym
Form: tablets, film-coated
Active substance Dosage ticagrelor 60 mg ATC: B01AC24
-
Igzelym
Form: tablets, film-coated
Active substance Dosage ticagrelor 90 mg ATC: B01AC24
-
Pazopanib accord
Form: tablets, film-coated
Active substance Dosage pazopanib 200 mg ATC: L01EX03
-
Pazopanib accord
Form: tablets, film-coated
Active substance Dosage pazopanib 400 mg ATC: L01EX03
-
Pazopanib pharmascience
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 200 mg ATC: L01XE03
-
Pazopanib pharmascience
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 400 mg ATC: L01XE03
-
Pazopanib zentiva
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 200 mg ATC: L01EX03
-
Pazopanib zentiva
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 400 mg ATC: L01EX03
-
Sorafenib mylan
Form: tablets, film-coated
Active substance Dosage sorafenib 200 mg ATC: L01EX02
-
Sorafenib pharmascience
Form: tablets, film-coated
Active substance Dosage sorafenib 200 mg ATC: L01EX02
-
Sorafenib stada
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg ATC: L01EX02
-
Tagant
Form: tablets, film-coated
Active substance Dosage enzalutamide 40 mg ATC: L02BB04
-
Tagant
Form: tablets, film-coated
Active substance Dosage enzalutamide 80 mg ATC: L02BB04
-
Xuvelex xr
Form: tablets, prolonged release
Active substance Dosage Metformin 389.938 mg ATC: A10BA02
-
Xuvelex xr
Form: tablets, prolonged release
Active substance Dosage Metformin 584.907 mg ATC: A10BA02
-
Xuvelex xr
Form: tablets, prolonged release
Active substance Dosage metformin hydrochloride 1000 mg ATC: A10BA02